Marex Group PLC Biomea Fusion, Inc. Transaction History
Marex Group PLC
- $12.2 Billion
- Q3 2025
A detailed history of Marex Group PLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Marex Group PLC holds 100,000 shares of BMEA stock, worth $128,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000
Previous 45,000
122.22%
Holding current value
$128,000
Previous $81,000
149.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BMEA
# of Institutions
86Shares Held
19MCall Options Held
289KPut Options Held
336K-
Cormorant Asset Management, LP Boston, MA3.57MShares$4.57 Million1.15% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$2.78 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$2.62 Million0.94% of portfolio
-
Heights Capital Management, Inc San Francisco, CA1.44MShares$1.84 Million0.8% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $37.5M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...